20160128 EGA Regulatory and Scientific Affairs Conferenc

EGA becomes Medicines for Europe

10 March 2016

The European Generic and Biosimilar Medicines Association is now Medicines […]

Read more

IGBA calls for full transparency and new timelines for impact assessment with regard to the voluntary WHO biological qualifier (BQ) proposal

2 March 2016


Medicines for Europe: Better Access, Better Health

1 March 2016


EGA Prioritises Pursuing Sustainability Agreements

12 February 2016


The European Biosimilars Group Appoints New Leadership Team With Sandoz’ Carol Lynch and Polpharma’s Klaus Martin

10 February 2016

Last week in Brussels, the European Biosimilar medicines Group (EBG […]

Read more

EGA Welcomes the Delegated Regulation as a Tool To Fight Counterfait Medicines

9 February 2016

Brussels – The European Generic and Biosimilar Medicines Association (EGA) welcomes […]

Read more

Shaping The 2020 Regulatory Landscape For Patient Needs

28 January 2016

London – 61 regulators from 25 countries made progress in improving the […]

Read more

Industry Coming Together To Improve Safety For Patients

26 January 2016

London – In London this week, the European Generic and Biosimilar medicines […]

Read more

Piden fabricar genéricos en periodo de extensión

25 January 2016

El presidente de la EGA considera que actualmente la industria […]

Read more

Global Pharmaceutical Industry Calls on Governments to Work with Them to Beat the Rising Threat of Drug Resistance

21 January 2016

More than 80 leading international pharmaceutical, generics, diagnostics and biotechnology […]

Read more

Subscribe to our newsletter